| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329685 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329665 Quinazolinone derivative |
| 02/12/2008 | CA2315532C Cyclopeptide derivatives with integrin inhibitor properties |
| 02/12/2008 | CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 02/12/2008 | CA2190802C A method of preparing and recovering proteins |
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |
| 02/07/2008 | WO2008015763A1 Drug formulation containing fibrate medicament and process for producing the same |
| 02/07/2008 | WO2007146719A3 2-aminocarbonylphenylamino-2-phenylacetamides as factor viia inhibitors useful as anticoagulants |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033009 Solid Pharmaceutical Formulation |
| 02/07/2008 | US20080032992 New Pyridine Analogues V |
| 02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080032952 Combination Therapies Employing Nicotinic Acid Derivatives or Fibric Acid Derivatives |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031861 Dietary supplements containing natural ingredients |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | DE4435392B4 Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF Process for the separation of vWF in high molecular weight vWF and low molecular weight vWF |
| 02/07/2008 | DE102006036023A1 Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität Imino-imidazo-pyridine derivatives with antithrombotic activity |
| 02/07/2008 | DE102005047558A1 Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen Combination therapy substituted oxazolidinones for the prophylaxis and treatment of cerebral circulatory disorders |
| 02/07/2008 | CA2657394A1 Preparation containing fibrate agent and process for producing the same |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
| 02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/06/2008 | EP1884235A1 Myeloerythroid progenitor differentiation inducer |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP1015089B1 Blood processing system and method which optically derives the volume of platelets contained in a plasma constituent |
| 02/06/2008 | CN101119747A Tissue factor production inhibitor |
| 02/06/2008 | CN101117630A Preparation method of nattokinase powder and natto Brazil mushroom capsule |
| 02/06/2008 | CN101116704A Oral Chinese traditional medicine composition for treating dysfunctional uterine bleeding |
| 02/06/2008 | CN101116697A Chinese traditional medicine composition for treating deficiency-cold type purpura |
| 02/06/2008 | CN101116696A Chinese traditional medicine composition for treating blood-heat type purpura |
| 02/06/2008 | CN101116694A Chinese traditional medicine for treating angitis, method for preparing the same and uses thereof |
| 02/06/2008 | CN101116684A Mongolian medicine for treating cerebrovascular disease |
| 02/06/2008 | CN101116661A Application of 5-hydroxymethyl furfural in the preparation of medicine for protecting vascellum endothelial cell |
| 02/06/2008 | CN101116523A Small red bean beverage |
| 02/06/2008 | CN100366277C Medicine composition for treating cardiac and cerebral vascular diseases and its prepn |
| 02/06/2008 | CN100366275C Method for controlling quality of Yunnan red tablet |
| 02/06/2008 | CN100366258C Application of ursane type triterpenoid saponin in the preparing process of leucocyte and/or platelet increasing medicine |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | CA2156255C Soluble thrombomodulin-containing composition |
| 01/31/2008 | WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 01/31/2008 | WO2007109459A3 Pyridines and pyridine n-oxides as modulators of thrombin |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027132 1,1,1,3,3,3-hexachloro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)benzoate; side effect reduction over warfarin |
| 01/31/2008 | US20080027126 Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027076 Pyrimidines With Tie2 (Tek) Activity |
| 01/31/2008 | US20080027068 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080026994 Modified vitamin K-dependent polypeptides |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080025921 Conductance of Improperly Folded Proteins Through the Secretory Pathway And Related Methods For Treating Disease |
| 01/31/2008 | US20080025918 Invisible light fluorescent platelets for intraoperative detection of vascular thrombosis |
| 01/31/2008 | DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs |
| 01/31/2008 | CA2658204A1 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | CN101112551A Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 01/30/2008 | CN101112481A Medicine for treating functional uterine bleeding and method for preparing the same |
| 01/30/2008 | CN101112395A Medicine for treating lymphatic disease |
| 01/30/2008 | CN101112358A Staphylokinase intramuscular injection and method for preparing the same |
| 01/30/2008 | CN100365117C Pegylated and diglycosylated erythropoietin |
| 01/30/2008 | CN100365016C Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364612C Degraded agonist antibody |
| 01/30/2008 | CN100364610C Method for raising utilizing degree to oral organism-absorbing of lumbrukinase |
| 01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
| 01/30/2008 | CN100364595C Compound Chinese herbal medicine of fossil, and preparation method |
| 01/30/2008 | CN100364545C Dogwood fruit extract and its preparing method and use |
| 01/30/2008 | CN100364544C Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/30/2008 | CN100364523C Simple production process for zinc citrate, zinc lactate, ferrous citrate and ferrous lactate |
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/29/2008 | US7323442 Due to bacteria infections; administering lactoferrin |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | CA2345484C Hemostatic agent, method and carrier for applying a blood clotting agent |
| 01/29/2008 | CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide |
| 01/29/2008 | CA2090650C Method of producing tissue factor pathway inhibitor |
| 01/24/2008 | WO2008010511A1 Screening method |